Published: 11 August 2023
Author(s): Kazuhisa Kaneda, Yugo Yamashita, Takeshi Morimoto, Ryuki Chatani, Yuji Nishimoto, Nobutaka Ikeda, Yohei Kobayashi, Satoshi Ikeda, Kitae Kim, Moriaki Inoko, Toru Takase, Shuhei Tsuji, Maki Oi, Takuma Takada, Kazunori Otsui, Takeshi Kimura, COMMAND VTE Registry-2 Investigators
Section: Original article

Venous thromboembolism (VTE), including pulmonary embolism (PE) and deep vein thrombosis (DVT), is a major health problem all over the world [1]. VTE has a long-term risk of recurrence, and the prevention of recurrent VTE by anticoagulation therapy is essential for the long-term management of patients with VTE [2]. International Society on Thrombosis and Haemostasis (ISTH) recommends classifications of risk of recurrent VTE based on whether an episode of VTE is unprovoked or provoked by an environmental risk factor and, if it is provoked, whether the provoking risk factor is transient or persistent [3].

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness